Clinically significant thromboembolic disease in orthopedic oncology: An analysis of 986 patients treated with low molecular-weight heparin

J Surg Oncol. 2010 Nov 1;102(6):549-50. doi: 10.1002/jso.21669.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Bone Neoplasms / complications
  • Bone Neoplasms / surgery*
  • Heparin, Low-Molecular-Weight / standards
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Pulmonary Embolism / prevention & control*
  • Standard of Care
  • Thromboembolism / drug therapy*

Substances

  • Heparin, Low-Molecular-Weight